| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2002;106:304.)
© 2002 American Heart Association, Inc.
Clinical Investigation and Reports |
From the Department of Epidemiology, University of Michigan, Ann Arbor, Mich (P.A.P., L.F.B., J.S.C.); Division of Hypertension, Department of Internal Medicine (S.T.T.), and Department of Diagnostic Radiology (P.F.S.), Mayo Clinic and Foundation, Rochester, Minn; Gene and Drug Discovery Center, Windber Research Institute, Windber, Pa (D.L.E.); and Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston (E.B.).
Correspondence to Patricia A. Peyser, University of Michigan, Department of Epidemiology, 109 Observatory, Ann Arbor, MI 48109. E-mail ppeyser{at}umich.edu
Background Electron beam computed tomography is an accurate, noninvasive method to detect and quantify coronary artery calcification (CAC), a marker of subclinical and clinical coronary artery atherosclerosis. CAC quantity predicts future coronary artery disease end points in asymptomatic adults, but measured risk factors explain less than half the variability in CAC quantity. Although several candidate genes for CAC have been identified, the relative importance of genetic influences on CAC quantity has not been assessed in asymptomatic adults in a community.
Methods and Results We quantified the relative contributions of measured risk factors and genetic influences on CAC quantity measured by electron beam computed tomography in 698 asymptomatic white adults from 302 families. Before adjusting for any risk factors, 43.5% of the variation in CAC quantity was attributable to genetic factors (P=0.0007). Independent predictors of CAC quantity were identified with stepwise linear regression. After adjusting for these risk factors, including age, sex, fasting glucose level, systolic blood pressure, pack-years of smoking, and LDL cholesterol, 41.8% of the residual variation in CAC quantity was attributable to genetic factors (P=0.0003).
Conclusions These results demonstrate the importance of genetic factors in subclinical coronary atherosclerosis variation as measured by CAC quantity. The presence of genetic effects suggests that unknown genes that influence CAC quantity are yet to be identified.
Key Words: genetics calcium atherosclerosis imaging epidemiology
This article has been cited by other articles:
![]() |
M. Bhakta, C. Bruce, D. Messika-Zeitoun, L. Bielak, P. F. Sheedy, P. Peyser, and M. Sarano Oral Calcium Supplements Do Not Affect the Progression of Aortic Valve Calcification or Coronary Artery Calcification J Am Board Fam Med, November 1, 2009; 22(6): 610 - 616. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rampersaud, L. F. Bielak, A. Parsa, H. Shen, W. Post, K. A. Ryan, P. Donnelly, J. A. Rumberger, P. F. Sheedy II, P. A. Peyser, et al. The Association of Coronary Artery Calcification and Carotid Artery Intima-Media Thickness With Distinct, Traditional Coronary Artery Disease Risk Factors in Asymptomatic Adults Am. J. Epidemiol., November 1, 2008; 168(9): 1016 - 1023. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. O'Donnell and E. G. Nabel Cardiovascular Genomics, Personalized Medicine, and the National Heart, Lung, and Blood Institute: Part I: The Beginning of an Era Circ Cardiovasc Genet, October 1, 2008; 1(1): 51 - 57. [Full Text] [PDF] |
||||
![]() |
F. S. Ertas, T. Hasan, C. Ozdol, S. Gulec, Y. Atmaca, C. Tulunay, H. Karabulut, H. T. Kocum, I. Dincer, K. S. Kose, et al. Relationship Between Angiotensin-Converting Enzyme Gene Polymorphism and Severity of Aortic Valve Calcification Mayo Clin. Proc., August 1, 2007; 82(8): 944 - 948. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Cassidy-Bushrow, L. F. Bielak, P. F. Sheedy II, S. T. Turner, I. J. Kullo, X. Lin, and P. A. Peyser Coronary Artery Calcification Progression Is Heritable Circulation, July 3, 2007; 116(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group Circulation, June 5, 2007; 115(22): 2878 - 2901. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Mazzone, P. M. Meyer, G. T. Kondos, M. H. Davidson, S. B. Feinstein, R. B. D'Agostino Sr., A. Perez, and S. M. Haffner Relationship of Traditional and Nontraditional Cardiovascular Risk Factors to Coronary Artery Calcium in Type 2 Diabetes Diabetes, March 1, 2007; 56(3): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Bella, W. Tang, A. Kraja, D. C. Rao, S. C. Hunt, M. B. Miller, V. Palmieri, M. J. Roman, D. W. Kitzman, A. Oberman, et al. Genome-Wide Linkage Mapping for Valve Calcification Susceptibility Loci in Hypertensive Sibships: The Hypertension Genetic Epidemiology Network Study Hypertension, March 1, 2007; 49(3): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Post, L. F. Bielak, K. A. Ryan, Y.-C. Cheng, H. Shen, J. A. Rumberger, P. F. Sheedy II, A. R. Shuldiner, P. A. Peyser, and B. D. Mitchell Determinants of Coronary Artery and Aortic Calcification in the Old Order Amish Circulation, February 13, 2007; 115(6): 717 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Garza, V. M. Montori, J. P. McConnell, V. K. Somers, I. J. Kullo, and F. Lopez-Jimenez Association Between Lipoprotein-Associated Phospholipase A2 and Cardiovascular Disease: A Systematic Review Mayo Clin. Proc., February 1, 2007; 82(2): 159 - 165. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. I. Freedman, D. W. Bowden, M. M. Sale, C. D. Langefeld, and S. S. Rich Genetic Susceptibility Contributes to Renal and Cardiovascular Complications of Type 2 Diabetes Mellitus Hypertension, July 1, 2006; 48(1): 8 - 13. [Full Text] [PDF] |
||||
![]() |
I. J. Kullo, L. F. Bielak, S. T. Turner, P. F. Sheedy II, and P. A. Peyser Aortic Pulse Wave Velocity Is Associated With the Presence and Quantity of Coronary Artery Calcium: A Community-Based Study Hypertension, February 1, 2006; 47(2): 174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K P Burdon, C D Langefeld, S R Beck, L E Wagenknecht, J J Carr, B I Freedman, D Herrington, and D W Bowden Association of genes of lipid metabolism with measures of subclinical cardiovascular disease in the Diabetes Heart Study J. Med. Genet., September 1, 2005; 42(9): 720 - 724. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Cassidy, L. F. Bielak, Y. Zhou, P. F. Sheedy II, S. T. Turner, J. F. Breen, P. A. Araoz, I. J. Kullo, X. Lin, and P. A. Peyser Progression of Subclinical Coronary Atherosclerosis: Does Obesity Make a Difference? Circulation, April 19, 2005; 111(15): 1877 - 1882. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fischer, U. Broeckel, S. Holmer, A. Baessler, C. Hengstenberg, B. Mayer, J. Erdmann, G. Klein, G. Riegger, H. J. Jacob, et al. Distinct Heritable Patterns of Angiographic Coronary Artery Disease in Families With Myocardial Infarction Circulation, February 22, 2005; 111(7): 855 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Kullo and C. M. Ballantyne Conditional Risk Factors for Atherosclerosis Mayo Clin. Proc., February 1, 2005; 80(2): 219 - 230. [Abstract] [PDF] |
||||
![]() |
C. J. O'Donnell Family History, Subclinical Atherosclerosis, and Coronary Heart Disease Risk: Barriers and Opportunities for the Use of Family History Information in Risk Prediction and Prevention Circulation, October 12, 2004; 110(15): 2074 - 2076. [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, L. A. Fitzpatrick, D. Inoue, J.-H. Qiao, M. C. Fishbein, R. C. Detrano, P. K. Shah, and T. B. Rajavashisth Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification Endocr. Rev., August 1, 2004; 25(4): 629 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. London, C. Marty, S. J. Marchais, A. P. Guerin, F. Metivier, and M.-C. de Vernejoul Arterial Calcifications and Bone Histomorphometry in End-Stage Renal Disease J. Am. Soc. Nephrol., July 1, 2004; 15(7): 1943 - 1951. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Doherty, L. A. Fitzpatrick, A. Shaheen, T. B. Rajavashisth, and R. C. Detrano Genetic Determinants of Arterial Calcification Associated With Atherosclerosis Mayo Clin. Proc., February 1, 2004; 79(2): 197 - 210. [Abstract] [PDF] |
||||
![]() |
J. F. Meschia and T. C. Gerber Editorial Comment--Vascular Thickness and Calcification as Markers of Atherosclerotic Burden Stroke, October 1, 2003; 34(10): 2372 - 2373. [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2002 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |